codice protocollo
P20-095 UPHOLD

Upadacitinib treatment patterns, achievement of treatment targets and maintenance of response in moderate to severe Rheumatoid Arthritis patients in real-world practice. (UPHOLD)

data di chiusura
mercoledì 10 aprile 2024
sperimentatore principale
Luca Quartuccio
allegati